US Edition
News from Eyewire+
Top Eyewire+ News
Diabetes · GermanyA new cohort study published in JAMA Ophthalmology suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), widely used for managing diabetes and obesity, may be associated with a lower risk of uveitis compared with matched controls.[1] These findings hint at potential anti-inflammatory effects of GLP-1 RAs beyond their metabolic benefits, offering an avenue for future research into ocular inflammatory disorders. The retrospective co…See the Story
GLP-1 Receptor Agonists Linked to Reduced Uveitis Risk
VaccinesWASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has begun publishing adverse event data from the FDA Adverse Event Reporting System (FAERS) on a daily basis, marking a major shift toward greater transparency and real-time monitoring of potential safety risks tied to prescription drugs and therapeutic biologics. The move, announced Friday, reflects the FDA’s ongoing modernization efforts to strengthen its safety monitoring infrastr…See the Story
